Helping childhood cancer survivors and their doctors improve colorectal cancer screening
The ASPIRES Study: Activating Cancer Survivors and their Primary Care Providers to Increase Colorectal Cancer Screening
This study is looking to help childhood cancer survivors who had radiation treatment in their belly or pelvis and are at a higher risk for colorectal cancer by using a digital program to encourage them and their doctors to follow screening guidelines better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11030321 on NIH RePORTER |
What this research studies
This research focuses on childhood cancer survivors who have undergone abdominal or pelvic radiotherapy and are at a higher risk of developing colorectal cancer. It aims to improve adherence to colorectal cancer screening guidelines through a digital health intervention that activates both the survivors and their primary care providers. The study will involve a randomized controlled trial with 315 participants, assessing the effectiveness of different activation strategies to encourage screening. By utilizing remote digital tools, the research seeks to bridge the gap in follow-up care for these high-risk individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are childhood cancer survivors aged 30 and older who have received abdominal or pelvic radiotherapy.
Not a fit: Patients who have not undergone abdominal or pelvic radiotherapy or are under the age of 30 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase colorectal cancer screening rates among childhood cancer survivors, leading to earlier detection and improved survival outcomes.
How similar studies have performed: Previous research has shown that digital health interventions can effectively improve screening rates in various populations, suggesting potential success for this novel approach.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Henderson, Tara Olive — University of Chicago
- Study coordinator: Henderson, Tara Olive
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.